Chao Liu

7PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 16, 2026
Elevated CHAF1A suppresses type I interferon production and causes immunotherapy resistance in esophageal squamous cell carcinoma.

|Apr 08, 2026
USP15 Promotes Pancreatic Cancer Progression and Cisplatin Resistance By Activating DNA Damage Repair.

Zhigang Ma, Hengzhen Li, Guangchun Zeng

|Oct 30, 2025
A Robust Immunohistochemistry-Based Classification for BRAF V600E-Mutant Colorectal Cancer With Clinical Implications.

Chao Liu, Yuli Ruan, Tong Wu

|May 05, 2025
USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment.

Shuling Han, Luying Cui, Bojun Wang

|Dec 09, 2024
Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer.

Luying Cui, Ruiqi Liu, Shuling Han

|Dec 09, 2024
Multiomics Reveals the Immunologic Features and the Immune Checkpoint Blockade Potential of Colorectal Medullary Carcinoma.

Chao Liu, Haoyi Zou, Yuli Ruan

Pageof 2

Frequent Collaborators

6 joint publications

Yanqiao Zhang

4 joint publications

Bojun Wang

3 joint publications

Yuli Ruan

3 joint publications

Luying Cui